Learn on: - A better knowledge of cancer biology that has led to a molecular segmentation of cancer
- New clinical trial designs that have been set up in order to overcome the challenge of small molecularly-defined patient populations: these trials include basket trials (histologic stratification) and umbrella trials (molecular stratification), but also trials that mix tumor types, targets and drugs that only assess the efficiency of the treatment algorithm used to allocate drugs to patients
- Challenges of these designs will be discussed, as well as perspectives on how to speed up drug development in the era of precision medicine
By Prof Christophe Le Tourneau, MD, PhD:Senior Medical Oncologist at the Institut Curie and Full Professor of Medicine at Paris-Saclay University
More info: www.IDDI.com

свернуть